Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Grass Pollen Allergy Vaccine

Clinical trial NCT00133146 · COMPLETED

Trial details

NCT number: NCT00133146
Sponsor: Allergy Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type I Hypersensitivity

Start date: 2005-09-12
Primary completion: 2005-11-23
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.